Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.

Antiviral therapy - 1 Jan 2008

Bertagnolio Silvia, Derdelinckx Inge, Parker Monica, Fitzgibbon Joseph, Fleury Herve, Peeters Martin, Schuurman Rob, Pillay Deenan, Morris Lynn, Tanuri Amilcar, Gershy-Damet Guy-Michel, Nkengasong John, Gilks Charles F, Sutherland Donald, Sandstrom Paul

Abstract excerpt

With rapidly increasing access to antiretroviral drugs globally, HIV drug resistance (HIVDR) has become a significant public health issue. This requires a coordinated and collaborative response from country level to international level to assess the extent of HIVDR and the establishment of efficient and evidence-based strategies to minimize its appearance and onward transmission. In parallel with the rollout of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Developing Countries

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to International Cooperation

Share to Laboratories

Share to National Health Programs

Share to Quality Assurance, Health Care

Share to Specimen Handling

Share to World Health Organization

Source

Identifiers

PMID: 18575191

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.PMID 18575191Read ↗

The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.Semantic proximity Read ↗

HIV-1 drug resistance and resistance testing.Semantic proximity Read ↗

Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.Semantic proximity Read ↗

European recommendations for the clinical use of HIV drug resistance testing: 2011 update.Semantic proximity Read ↗

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA PanelSemantic proximity Read ↗

Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals.Semantic proximity Read ↗

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.Semantic proximity Read ↗

An overview of the human immunodeficiency virus featuring laboratory testing for drug resistance.Semantic proximity Read ↗

The use of human immunodeficiency virus resistance tests in clinical practice.Semantic proximity Read ↗

World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.Semantic proximity Read ↗

HIV drug resistance testing.Semantic proximity Read ↗

Technologies for HIV-1 drug resistance testing: inventory and needs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.